Literature DB >> 34194908

Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation.

Atiya Rahman1, Mohd Aqil1, Abdul Ahad2, Syed Sarim Imam2, Abdul Qadir1, Asgar Ali1.   

Abstract

Onychomycosis is a common fungal infection of the nails that mostly affects the elderly and athletes. Antifungal drug-like itraconazole is one of the therapeutic agents of choice for the topical treatment of onychomycosis. The current work aimed for the preparation and optimization of itraconazole-loaded nail lacquer formulation. Central composite design was employed; independent variables were polymer concentration (X1) and thioglycolic acid (TGA) concentration (X2). While the dependent variables were cumulative amount of drug permeated per unit area (CADP/A, Y1), drying time (Y2) and nonvolatile content (Y3). The optimized formulation was characterized for various parameters including ex-vivo permeation study, confocal laser scanning microscopy (CLSM) and antifungal study. The optimized nail lacquer formulation (F7) exhibited CADP/A of 198.23 µg/cm2, drying time of 185 s and nonvolatile content of 97.23%. The scanning electron microscopy of goat hoof treated with optimized nail lacquer formulation demonstrated loosening of the structure and marked increase in surface roughness. The CLSM micrograph of goat hoof treated with optimized nail lacquer formulation demonstrated that the probe dye was eventually distributed and penetrated through the hoof. Bio-adhesiveness analysis showed that the prepared nail lacquer film has ample adhesiveness to be maintained on the nail plate surface for a sufficient time. In antifungal study, the optimized nail lacquer, and marketed gel exhibited a zone inhibition of 21 mm, and 10 mm against Candida albicans, respectively. The stability study showed that the optimized nail lacquer is stable at storage condition. The prepared nail lacquers have been shown to serve as a useful dosage form for the delivery of itraconazole across nail plate for controlling the problems associated with onychomycosis. © King Abdulaziz City for Science and Technology 2021.

Entities:  

Keywords:  Central composite design; Itraconazole; Onychomycosis; Transungual

Year:  2021        PMID: 34194908      PMCID: PMC8196131          DOI: 10.1007/s13205-021-02862-0

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.893


  36 in total

Review 1.  Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.

Authors:  Xiaowei Feng; Xincai Xiong; Yuping Ran
Journal:  Dermatol Ther       Date:  2017-01-18       Impact factor: 2.851

2.  A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails.

Authors:  Mahmoud Ghannoum; Lisa Long; Gernot Kunze; Marlis Sarkany; Hanan Osman-Ponchet
Journal:  Mycoses       Date:  2019-03-18       Impact factor: 4.377

Review 3.  Insights into drug delivery across the nail plate barrier.

Authors:  Manish V Saner; Abhijeet D Kulkarni; Chandrakantsing V Pardeshi
Journal:  J Drug Target       Date:  2014-06-25       Impact factor: 5.121

4.  Enhanced Ungual Permeation of Terbinafine HCl Delivered Through Liposome-Loaded Nail Lacquer Formulation Optimized by QbD Approach.

Authors:  Viral H Shah; Amee Jobanputra
Journal:  AAPS PharmSciTech       Date:  2017-07-05       Impact factor: 3.246

5.  Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.

Authors:  D Monti; L Saccomani; P Chetoni; S Burgalassi; S Senesi; E Ghelardi; F Mailland
Journal:  Br J Dermatol       Date:  2009-11-03       Impact factor: 9.302

6.  Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.

Authors:  Eman A Bseiso; Maha Nasr; Omaima A Sammour; Nabaweya A Abd El Gawad
Journal:  Drug Deliv       Date:  2015-10-08       Impact factor: 6.419

Review 7.  Onychomycosis: pathogenesis, diagnosis, and management.

Authors:  B E Elewski
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

8.  Optimization of valencene containing lipid vesicles for boosting the transungual delivery of itraconazole.

Authors:  Quamrul Hoda; Mohd Aqil; Abdul Ahad; Syed Sarim Imam; Arshiya Praveen; Abdul Qadir; Zeenat Iqbal
Journal:  3 Biotech       Date:  2021-02-22       Impact factor: 2.406

Review 9.  Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis.

Authors:  Bianca Maria Piraccini; Matilde Iorizzo; André Lencastre; Pietro Nenoff; Dimitris Rigopoulos
Journal:  Dermatol Ther (Heidelb)       Date:  2020-07-23

10.  Improved skin permeation of methotrexate via nanosized ultradeformable liposomes.

Authors:  Alam Zeb; Omer Salman Qureshi; Hyung-Seo Kim; Ji-Hye Cha; Hoo-Seong Kim; Jin-Ki Kim
Journal:  Int J Nanomedicine       Date:  2016-08-08
View more
  2 in total

1.  Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.

Authors:  Deepa Dehari; Abhishesh Kumar Mehata; Vishnu Priya; Dharmnath Parbat; Deepak Kumar; Anand Kumar Srivastava; Sanjay Singh; Ashish Kumar Agrawal
Journal:  AAPS PharmSciTech       Date:  2022-06-24       Impact factor: 4.026

2.  Printing Drugs onto Nails for Effective Treatment of Onychomycosis.

Authors:  Thomas D Pollard; Margherita Bonetti; Adam Day; Simon Gaisford; Mine Orlu; Abdul W Basit; Sudaxshina Murdan; Alvaro Goyanes
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.